<DOC>
	<DOCNO>NCT02946307</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety RESTORE Paclitaxel elute balloon treatment Chinese patient coronary heart disease small vessel lesion comparison RESOLUTE Zotarolimus elute stent .</brief_summary>
	<brief_title>Assess Efficacy Safety RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent Treatment Small Coronary Vessel Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>Related patient : 1 . Age ≥18 year old 2 . Patients stable unstable angina pectoris , recent myocardial infarction stabilize ( occurred 7 day enrollment , include nonst segment elevation myocardial infarction ( NSTMI ) STMI ) , prove asymptomatic regional myocardial ischemia 3 . Patients small vessel cohort suitable balloon dilation angioplasty stent implantation , patient small vessel cohort suitable balloon dilation angioplasty . 4 . Patients sufficient compliance agree receive followup month1 , 6 , 9 12 , followup visit year2 , 3 , 4 , 5 . It require perform angiography month9 . 5 . Patients volunteer participate study , sign write informed consent form , understand risk benefit inform consent document . Related disease : 6 . Patients de novo , situ lesion small coronary vessel , length lesion ≤26mm accord visual inspection . In small vessel cohort , diameter target lesion ≥2.25mm ≤2.75mm accord visual inspection , small vessel cohort , diameter target lesion ≥2 . 00mm &lt; 2.25mm accord visual inspection . 7 . The diameter stenosis accord visual inspection intervention treatment ≥70 % ≥50 % evidence ischemia . 8 . Each patient allow one lesion target small vessel ( 2 lesion distance ≤10mm total length ≤26mm could treat balloon stent consider one lesion ) . Related patient : 1 . Myocardial infarction occur within 1 week enrollment . 2 . Patients severe congestive heart failure New York Heart Association ( NYHA ) grade IV heart failure 3 . Left ventricular ejection fraction ( LVEF ) &lt; 35 % 4 . Patients heart transplantation 5 . Patients severe valvular heart disease 6 . The patient cerebral stroke within 6 month include , history peptic ulcer gastrointestinal bleeding past 6 month , patient bleed tendency accord investigator . 7 . Patients history leukopenia ( white blood cell count &lt; 3×109/L 3 day ) neutropenia ( ANC &lt; 1000/mm3 3 day ) thrombocytopenia ( platelet &lt; 100,000/mm3 ) 8 . Patients renal insufficiency ( eGFR &lt; 30ml/min ) 9 . Patients forbidden use anticoagulation agent antiplatelet drug , unable tolerate Aspirin Clopidogrel 10 . Patients know allergic Paclitaxel Zotarolimus 11 . The patient life expectancy le 1 year , would difficult finish followup within 1 year . 12 . Pregnant lactate woman , female patient childbearing age plan get pregnant period study could take effective contraceptive 13 . The patient participate clinical trial drug device reach primary endpoint . 14 . Patients unsuitable study accord investigator due reason Related disease : 15 . Patients total occlusion target vessel 16 . The patient severe calcification target lesion , therefore balloon predilation could perform successfully . 17 . The target lesion bifurcation lesion diameter branch vessel &gt; 2.00mm . 18 . The target lesion instent restenosis . 19 . Angiography indicate thrombosis target vessel . 20 . Complicated lesion leave main ( LM ) require intervention treatment 21 . There 2 nontarget lesion require treatment , could treat intervention target lesion , treatment fail .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>